{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:54:02Z","timestamp":1784314442693,"version":"3.55.0"},"reference-count":63,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Persistent Rel\/nuclear factor-\u03baB (NF-\u03baB) activity is a hallmark of many human cancers, and the Rel proteins are implicated in leukemia\/lymphomagenesis but the mechanism is not fully understood. Microarray analysis to identify transformation-impacting genes regulated by NF-\u03baB's oncogenic v-Rel and c-Rel proteins uncovered that Rel protein expression leads to transcriptional repression of key B-cell receptor (BCR) components and signaling molecules like B-cell linker (BLNK), the B-cell adaptor for phosphoinositide 3-kinase (BCAP) and immunoglobulin \u03bb light chain (Ig\u03bb), and is accompanied by a block in BCR-mediated activation of extracellular signal-regulated kinase, Akt, and c-Jun-NH2-kinase in response to anti-IgM. The BLNK and BCAP proteins were also down-regulated in lymphoid cells expressing a transformation-competent chimeric RelA\/v-Rel protein, suggesting a correlation with the capacity of Rel proteins to transform lymphocytes. DNA-binding studies identified functional NF-\u03baB\u2013binding sites, and chromatin immunoprecipitation (ChIP) data showed binding of Rel to the endogenous blnk and bcap promoters in vivo. Importantly, restoration of either BLNK or BCAP expression strongly inhibited transformation of primary chicken lymphocytes by the potent NF-\u03baB oncoprotein v-Rel. These findings are interesting because blnk and other BCR components and signaling molecules are down-regulated in primary mediastinal large B-cell lymphomas and Hodgkin's lymphomas, which depend on c-Rel for survival, and are consistent with the tumor suppressor function of BLNK. Overall, our results indicate that down-regulation of BLNK and BCAP is an important contributing factor to the malignant transformation of lymphocytes by Rel and suggest that gene repression may be as important as transcriptional activation for Rel's transforming activity. [Cancer Res 2008;68(3):808\u201314]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-3169","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T14:04:44Z","timestamp":1201874684000},"page":"808-814","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Repression of B-Cell Linker (BLNK) and B-Cell Adaptor for Phosphoinositide 3-Kinase (BCAP) Is Important for Lymphocyte Transformation by Rel Proteins"],"prefix":"10.1158","volume":"68","author":[{"given":"Nupur","family":"Gupta","sequence":"first","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2Graduate Program in Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Delrow","sequence":"additional","affiliation":[{"name":"5Fred Hutchinson Cancer Research Center, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Drawid","sequence":"additional","affiliation":[{"name":"4BioMAPS Institute for Quantitative Biology, Rutgers University, Piscataway, New Jersey;"},{"name":"6sanofi-aventis, Bridgewater, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirvan M.","family":"Sengupta","sequence":"additional","affiliation":[{"name":"4BioMAPS Institute for Quantitative Biology, Rutgers University, Piscataway, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Fan","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2Graduate Program in Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301line","family":"Ge\u0301linas","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"3Department of Biochemistry, Robert Wood Johnson Medical School;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"2022061700404298100_B1","doi-asserted-by":"crossref","unstructured":"Zhang JY, Olson W, Ewert D, Bargmann W, Bose HR, Jr. The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro. Virology\u20081991; 183: 457\u201366.","DOI":"10.1016\/0042-6822(91)90975-H"},{"key":"2022061700404298100_B2","doi-asserted-by":"crossref","unstructured":"Hrdlickova R, Nehyba J, Humphries EH. In vivo evolution of c-rel oncogenic potential. J Virol\u20081994; 68: 2371\u201382.","DOI":"10.1128\/jvi.68.4.2371-2382.1994"},{"key":"2022061700404298100_B3","doi-asserted-by":"crossref","unstructured":"Nehyba J, Hrdlickova R, Humphries EH. Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation. J Virol\u20081994; 68: 2039\u201350.","DOI":"10.1128\/jvi.68.4.2039-2050.1994"},{"key":"2022061700404298100_B4","doi-asserted-by":"crossref","unstructured":"Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene\u20082001; 20: 7098\u2013103.","DOI":"10.1038\/sj.onc.1204898"},{"key":"2022061700404298100_B5","doi-asserted-by":"crossref","unstructured":"Romieu-Mourez R, Kim DW, Shin SM, et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol\u20082003; 23: 5738\u201354.","DOI":"10.1128\/MCB.23.16.5738-5754.2003"},{"key":"2022061700404298100_B6","doi-asserted-by":"crossref","unstructured":"Luo JL, Kamata H, Karin M. IKK\/NF-\u03baB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest\u20082005; 115: 2625\u201332.","DOI":"10.1172\/JCI26322"},{"key":"2022061700404298100_B7","doi-asserted-by":"crossref","unstructured":"Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene\u20082004; 23: 2275\u201386.","DOI":"10.1038\/sj.onc.1207410"},{"key":"2022061700404298100_B8","doi-asserted-by":"crossref","unstructured":"Barth TF, Martin-Subero JI, Joos S, et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood\u20082003; 101: 3681\u20136.","DOI":"10.1182\/blood-2002-08-2577"},{"key":"2022061700404298100_B9","doi-asserted-by":"crossref","unstructured":"Feuerhake F, Kutok JL, Monti S, et al. NF\u03baB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood\u20082005; 106: 1392\u20139.","DOI":"10.1182\/blood-2004-12-4901"},{"key":"2022061700404298100_B10","doi-asserted-by":"crossref","unstructured":"Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood\u20082003; 102: 3871\u20139.","DOI":"10.1182\/blood-2003-06-1841"},{"key":"2022061700404298100_B11","doi-asserted-by":"crossref","unstructured":"Weniger MA, Gesk S, Ehrlich S, et al. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein. Genes Chromosomes Cancer\u20082007; 46: 406\u201315.","DOI":"10.1002\/gcc.20420"},{"key":"2022061700404298100_B12","doi-asserted-by":"crossref","unstructured":"Bargou R, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-\u03baB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest\u20081997; 100: 2961\u20139.","DOI":"10.1172\/JCI119849"},{"key":"2022061700404298100_B13","doi-asserted-by":"crossref","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor \u03baB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med\u20082001; 194: 1861\u201374.","DOI":"10.1084\/jem.194.12.1861"},{"key":"2022061700404298100_B14","doi-asserted-by":"crossref","unstructured":"Wu M, Lee H, Bellas RE, et al. Inhibition of NF-\u03baB\/Rel induces apoptosis of murine B cells. EMBO J\u20081996; 15: 4682\u201390.","DOI":"10.1002\/j.1460-2075.1996.tb00845.x"},{"key":"2022061700404298100_B15","doi-asserted-by":"crossref","unstructured":"Fan Y, Rayet B, Ge\u0301linas C. Divergent C-terminal transactivation domains of Rel\/NF-kB proteins are critical determinants of their oncogenic potential in lymphocytes. Oncogene\u20082004; 23: 1030\u201342.","DOI":"10.1038\/sj.onc.1207221"},{"key":"2022061700404298100_B16","doi-asserted-by":"crossref","unstructured":"Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. Current insights into the regulation of programmed cell death by NF-kB. Oncogene\u20082006; 25: 6800\u201316.","DOI":"10.1038\/sj.onc.1209938"},{"key":"2022061700404298100_B17","doi-asserted-by":"crossref","unstructured":"Kralova J, Liss AS, Bargmann W, Bose HR, Jr. AP-1 factors play an important role in transformation induced by the v-rel oncogene. Mol Cell Biol\u20081998; 18: 2997\u20133009.","DOI":"10.1128\/MCB.18.5.2997"},{"key":"2022061700404298100_B18","doi-asserted-by":"crossref","unstructured":"Hrdlickova R, Nehyba J, Bose HR, Jr. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol Cell Biol\u20082001; 21: 6369\u201386.","DOI":"10.1128\/MCB.21.19.6369-6386.2001"},{"key":"2022061700404298100_B19","doi-asserted-by":"crossref","unstructured":"Kralova J, Liss AS, Bargmann W, et al. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel. J Virol\u20082002; 76: 11960\u201370.","DOI":"10.1128\/JVI.76.23.11960-11970.2002"},{"key":"2022061700404298100_B20","doi-asserted-by":"crossref","unstructured":"Hrdlickova R, Nehyba J, Liss AS, Bose HR, Jr. Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol\u20082006; 80: 281\u201395.","DOI":"10.1128\/JVI.80.1.281-295.2006"},{"key":"2022061700404298100_B21","doi-asserted-by":"crossref","unstructured":"Majid SM, Liss AS, You M, Bose HR. The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene\u20082006; 25: 756\u201368.","DOI":"10.1038\/sj.onc.1209107"},{"key":"2022061700404298100_B22","doi-asserted-by":"crossref","unstructured":"Neiman PE, Ruddell A, Jasoni C, et al. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci U S A\u20082001; 98: 6378\u201383.","DOI":"10.1073\/pnas.111144898"},{"key":"2022061700404298100_B23","doi-asserted-by":"crossref","unstructured":"Ishiai M, Kurosaki M, Pappu R, et al. BLNK required for coupling Syk to PLC \u03b32 and Rac1-JNK in B cells. Immunity\u20081999; 10: 117\u201325.","DOI":"10.1016\/S1074-7613(00)80012-6"},{"key":"2022061700404298100_B24","doi-asserted-by":"crossref","unstructured":"Fan Y, Gelinas C. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. Oncogene\u20082007; 26: 4038\u201343.","DOI":"10.1038\/sj.onc.1210164"},{"key":"2022061700404298100_B25","doi-asserted-by":"crossref","unstructured":"Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia\u20082000; 14: 399\u2013402.","DOI":"10.1038\/sj.leu.2401705"},{"key":"2022061700404298100_B26","doi-asserted-by":"crossref","unstructured":"Chen L, Lim MY, Bose H, J.M. B. Rearrangements of chicken immunoglobulin genes in lymphoid cells transformed by the avian retroviral oncogene v-rel. Proc Natl Acad Sci U S A\u20081988; 85: 549\u201353.","DOI":"10.1073\/pnas.85.2.549"},{"key":"2022061700404298100_B27","doi-asserted-by":"crossref","unstructured":"Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity\u20082000; 13: 817\u201327.","DOI":"10.1016\/S1074-7613(00)00079-0"},{"key":"2022061700404298100_B28","doi-asserted-by":"crossref","unstructured":"Simeoni L, Kliche S, Lindquist J, Schraven B. Adaptors and linkers in T and B cells. Curr Opin Immunol\u20082004; 16: 304\u201313.","DOI":"10.1016\/j.coi.2004.03.001"},{"key":"2022061700404298100_B29","doi-asserted-by":"crossref","unstructured":"Flemming A, Brummer T, Reth M, Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol\u20082003; 4: 38\u201343.","DOI":"10.1038\/ni862"},{"key":"2022061700404298100_B30","doi-asserted-by":"crossref","unstructured":"Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood\u20082003; 101: 1505\u201312.","DOI":"10.1182\/blood-2002-03-0839"},{"key":"2022061700404298100_B31","doi-asserted-by":"crossref","unstructured":"Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin\/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene\u20082002; 21: 4908\u201320.","DOI":"10.1038\/sj.onc.1205629"},{"key":"2022061700404298100_B32","doi-asserted-by":"crossref","unstructured":"Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-\u03baB. Cell Death Differ\u20082006; 13: 759\u201372.","DOI":"10.1038\/sj.cdd.4401838"},{"key":"2022061700404298100_B33","doi-asserted-by":"crossref","unstructured":"Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-\u03baB. Mol Cell\u20082004; 13: 853\u201365.","DOI":"10.1016\/S1097-2765(04)00131-5"},{"key":"2022061700404298100_B34","doi-asserted-by":"crossref","unstructured":"Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-\u03baB transactivation by the ARF tumor suppressor. Mol Cell\u20082003; 12: 15\u201325.","DOI":"10.1016\/S1097-2765(03)00223-5"},{"key":"2022061700404298100_B35","doi-asserted-by":"crossref","unstructured":"Jiang HY, Petrovas C, Sonenshein GE. RelB-p50 NF-\u03ba B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-\u03ba B family members. J Virol\u20082002; 76: 5737\u201347.","DOI":"10.1128\/JVI.76.11.5737-5747.2002"},{"key":"2022061700404298100_B36","doi-asserted-by":"crossref","unstructured":"Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-\u03baB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J\u20082005; 24: 1157\u201369.","DOI":"10.1038\/sj.emboj.7600608"},{"key":"2022061700404298100_B37","doi-asserted-by":"crossref","unstructured":"Campbell KJ, Witty JM, Rocha S, Perkins ND. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-\u03baB transactivation. Cancer Res\u20082006; 66: 929\u201335.","DOI":"10.1158\/0008-5472.CAN-05-2234"},{"key":"2022061700404298100_B38","doi-asserted-by":"crossref","unstructured":"Poppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D. NF\u03baB-dependent down-regulation of tumor necrosis factor receptor-associated proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis. J Biol Chem\u20082005; 280: 15635\u201343.","DOI":"10.1074\/jbc.M413006200"},{"key":"2022061700404298100_B39","doi-asserted-by":"crossref","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-\u03baB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A\u20082006; 103: 12481\u20136.","DOI":"10.1073\/pnas.0605298103"},{"key":"2022061700404298100_B40","doi-asserted-by":"crossref","unstructured":"Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol\u20081996; 12: 393\u2013416.","DOI":"10.1146\/annurev.cellbio.12.1.393"},{"key":"2022061700404298100_B41","doi-asserted-by":"crossref","unstructured":"Tumang JR, Owyang A, Andjelic S, et al. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur J Immunol\u20081998; 28: 4299\u2013312.","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y"},{"key":"2022061700404298100_B42","doi-asserted-by":"crossref","unstructured":"Kontgen F, Grumont RJ, Strasser A, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev\u20081995; 9: 1965\u201377.","DOI":"10.1101\/gad.9.16.1965"},{"key":"2022061700404298100_B43","doi-asserted-by":"crossref","unstructured":"Owyang AM, Tumang JR, Schram BR, et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol\u20082001; 167: 4948\u201356.","DOI":"10.4049\/jimmunol.167.9.4948"},{"key":"2022061700404298100_B44","doi-asserted-by":"crossref","unstructured":"Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev\u20081999; 13: 400\u201311.","DOI":"10.1101\/gad.13.4.400"},{"key":"2022061700404298100_B45","doi-asserted-by":"crossref","unstructured":"Grumont RJ, Rourke IJ, O'Reilly LA, et al. B lymphocytes differentially use the Rel and nuclear factor kB1 (NF-kB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med\u20081998; 187: 663\u201374.","DOI":"10.1084\/jem.187.5.663"},{"key":"2022061700404298100_B46","doi-asserted-by":"crossref","unstructured":"Feng B, Cheng S, Hsia CY, King LB, Monroe JG, Liou HC. NF-\u03baB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol\u20082004; 232: 9\u201320.","DOI":"10.1016\/j.cellimm.2005.01.006"},{"key":"2022061700404298100_B47","doi-asserted-by":"crossref","unstructured":"Tumang JR, Hsia CY, Tian W, Bromberg JF, Liou HC. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Cell Immunol\u20082002; 217: 47\u201357.","DOI":"10.1016\/S0008-8749(02)00513-0"},{"key":"2022061700404298100_B48","doi-asserted-by":"crossref","unstructured":"Tan JE, Wong SC, Gan SK, Xu S, Lam KP. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-\u03baB and cell cycle entry and survival of B lymphocytes. J Biol Chem\u20082001; 276: 20055\u201363.","DOI":"10.1074\/jbc.M010800200"},{"key":"2022061700404298100_B49","doi-asserted-by":"crossref","unstructured":"Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol\u20082003; 4: 780\u20136.","DOI":"10.1038\/ni949"},{"key":"2022061700404298100_B50","doi-asserted-by":"crossref","unstructured":"Beug H, Muller H, Doederlein G, Graf T. Hematopoietic cells transformed in vitro by REV-T avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells. Virology\u20081981; 115: 295\u2013309.","DOI":"10.1016\/0042-6822(81)90112-4"},{"key":"2022061700404298100_B51","doi-asserted-by":"crossref","unstructured":"Boehmelt G, Madruga J, Dorfler P, et al. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell\u20081995; 80: 341\u201352.","DOI":"10.1016\/0092-8674(95)90417-4"},{"key":"2022061700404298100_B52","doi-asserted-by":"crossref","unstructured":"Barth CF, Ewert DL, Olson WC, Humphries EH. Reticuloendotheliosis virus REV-T(REV-A)-induced neoplasia: development of tumors within the T-lymphoid and myeloid lineages. J Virol\u20081990; 64: 6054\u201362.","DOI":"10.1128\/jvi.64.12.6054-6062.1990"},{"key":"2022061700404298100_B53","doi-asserted-by":"crossref","unstructured":"Barth CF, Humphries EH. Expression of v-rel induces mature B-cell lines that reflect the diversity of avian immunoglobulin heavy- and light-chain rearrangements. Mol Cell Biol\u20081988; 8: 5358\u201368.","DOI":"10.1128\/mcb.8.12.5358-5368.1988"},{"key":"2022061700404298100_B54","doi-asserted-by":"crossref","unstructured":"Jumaa H, Mitterer M, Reth M, Nielsen PJ. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur J Immunol\u20082001; 31: 2164\u20139.","DOI":"10.1002\/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S"},{"key":"2022061700404298100_B55","doi-asserted-by":"crossref","unstructured":"Grabbe A, Wienands J. Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes. Blood\u20082006; 108: 3761\u20138.","DOI":"10.1182\/blood-2006-02-005397"},{"key":"2022061700404298100_B56","doi-asserted-by":"crossref","unstructured":"Papa S, Bubici C, Zazzeroni F, et al. The NF-\u03baB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ\u20082006; 13: 712\u201329.","DOI":"10.1038\/sj.cdd.4401865"},{"key":"2022061700404298100_B57","unstructured":"White DW, Roy A, Gilmore TD. The v-Rel oncoprotein blocks apoptosis and proteolysis of I\u03baB-\u03b1 in transformed chicken spleen cells. Oncogene\u20081995; 10: 857\u201368."},{"key":"2022061700404298100_B58","unstructured":"White DW, Gilmore TD. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I\u03baB-\u03b1 in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene\u20081996; 13: 891\u20139."},{"key":"2022061700404298100_B59","doi-asserted-by":"crossref","unstructured":"Bellas RE, Lee JS, Sonenshein GE. Expression of a constitutive NF-kB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest\u20081995; 96: 2521\u20137.","DOI":"10.1172\/JCI118313"},{"key":"2022061700404298100_B60","doi-asserted-by":"crossref","unstructured":"Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol\u20082002; 14: 905\u201316.","DOI":"10.1093\/intimm\/dxf055"},{"key":"2022061700404298100_B61","doi-asserted-by":"crossref","unstructured":"Cheng S, Hsia CY, Leone G, Liou H-C. Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-\/- B cells. Oncogene\u20082003; 22: 8472\u201386.","DOI":"10.1038\/sj.onc.1206917"},{"key":"2022061700404298100_B62","doi-asserted-by":"crossref","unstructured":"Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin's lymphoma. Ann Oncol\u20082002; 13 Suppl 1: 11\u20138.","DOI":"10.1093\/annonc\/13.S1.11"},{"key":"2022061700404298100_B63","doi-asserted-by":"crossref","unstructured":"Gilmore TD, Jean-Jacques J, Richards R, Cormier C, Kim J, Kalaitzidis D. Stable expression of the avian retroviral oncoprotein v-Rel in avian, mouse, and dog cell lines. Virology\u20082003; 316: 9\u201316.","DOI":"10.1016\/S0042-6822(03)00562-2"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/3\/808\/2599741\/808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/3\/808\/2599741\/808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:06:40Z","timestamp":1655431600000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/3\/808\/542122\/Repression-of-B-Cell-Linker-BLNK-and-B-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,2,1]]},"published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-3169","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6497589","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374810","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497589.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374810.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}